iShares Nasdaq Biotechnology (IBB)

Add to Watchlists
Create an Alert
285.14 +2.27  +0.80% NASDAQ Aug 26, 20:00 Delayed 2m USD
View Full Chart
IBB Price Chart

IBB Key Stats

Expense Ratio 0.47%
Share Class Assets Under Management 7.318B
30-Day Average Daily Volume Upgrade
Net Asset Value 285.29
Discount or Premium to NAV -0.05%
Turnover Ratio 24.00

IBB Asset Allocation

Type % Net % Long % Short
Cash 0.08% 0.08% 0.00%
Stock 99.92% 99.92% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.00% 0.00% 0.00%
As of Aug. 24, 2016

IBB Net Fund Flows

1M 155.80M
3M 292.03M
6M 580.53M
YTD 513.48M
1Y -359.01M
3Y 2.123B
5Y 2.788B
10Y 2.406B
As of July 31, 2016

IBB Net Share Class Flows

1M 155.80M
3M 292.03M
6M 580.53M
YTD 513.48M
1Y -359.01M
3Y 2.123B
5Y 2.788B
10Y 2.406B
As of July 31, 2016

IBB Region Exposure

Americas 95.24%
North America 95.24%
Latin America 0.00%
Greater Europe 4.24%
United Kingdom 3.34%
Europe Developed 0.71%
Europe Emerging 0.00%
Africa/Middle East 0.20%
Greater Asia 0.52%
Japan 0.00%
Australasia 0.00%
Asia Developed 0.00%
Asia Emerging 0.52%
Market Classification
% Developed Markets 99.48%
% Emerging Markets 0.52%
As of Aug. 24, 2016
Region breakdown data is calculated by using the long position holdings of the portfolio.

IBB Stock Sector Exposure

Basic Materials 0.00%
Communication Services 0.00%
Consumer Cyclical 0.00%
Consumer Defensive 0.00%
Energy 0.00%
Financial Services 0.00%
Healthcare 100.0%
Industrials 0.00%
Real Estate 0.00%
Technology 0.00%
Utilities 0.00%
As of Aug. 24, 2016

IBB Stock Market Capitalization

Giant 26.56%
Large 31.87%
Medium 19.96%
Small 11.14%
Micro 10.39%
As of Aug. 24, 2016

IBB Stock Style Exposure

Large Cap Value 0.00%
Large Cap Blend 3.17%
Large Cap Growth 58.30%
Mid Cap Value 1.94%
Mid Cap Blend 0.83%
Mid Cap Growth 18.24%
Small Cap Value 0.78%
Small Cap Blend 2.68%
Small Cap Growth 14.06%
As of Aug. 24, 2016
View More Holdings

IBB Top 10 Holdings

Symbol Name % Weight Price % Chg
AMGN Amgen Inc 8.34% 171.97 +1.02%
BIIB Biogen Inc 8.23% 308.17 +0.43%
CELG Celgene Corp 8.08% 108.79 +0.82%
GILD Gilead Sciences Inc 7.13% 79.77 -0.39%
REGN Regeneron Pharmaceuticals Inc 7.07% 402.97 +0.68%
ILMN Illumina Inc 4.39% 172.21 +1.61%
VRTX Vertex Pharmaceuticals Inc 4.01% 97.09 +0.74%
MYL Mylan NV 3.84% 43.03 +0.42%
ALXN Alexion Pharmaceuticals Inc 3.37% 129.63 +0.36%
SHPG Shire PLC ADR 3.01% 190.68 -0.52%
As of Aug. 24, 2016
Advertisement

One Page Reports

IBB Basic Info

Style
Equity Style Large Cap/Growth
Broad Asset Class Sector Equity
Broad Category Equity
Category Name Health
Prospectus Objective Specialty - Technology
Fund Owner Firm Name iShares
Benchmark Index
NASDAQ Biotechnology TR USD
100.0%

IBB Manager Info

Name Tenure
Alan Mason 0.29 yrs
Diane Hsiung 8.59 yrs
Greg Savage 8.59 yrs
Jennifer Hsui 4.00 yrs

IBB Risk Info

Beta 1.106
Max Drawdown (All) 62.85%
Historical Sharpe (10Y) 0.8077
Historical Sortino (All) 0.5719
30-Day Rolling Volatility 20.07%
Daily Value at Risk (VaR) 1% (All) 4.88%
Monthly Value at Risk (VaR) 1% (All) 19.79%

IBB Fundamentals

Dividend Yield TTM (8-26-16) 0.12%
Weighted Average PE Ratio 21.18
Weighted Average Price to Sales Ratio 6.425
Weighted Average Price to Book Ratio 5.093
Weighted Median ROE 12.34%
Weighted Median ROA 2.14%
Forecasted Dividend Yield 0.31%
Forecasted PE Ratio 20.72
Forecasted Price to Sales Ratio 5.291
Forecasted Price to Book Ratio 3.591
Number of Holdings 189
As of Aug. 24, 2016

IBB Growth Estimates

Forecasted 5 Yr Earnings Growth 14.65%
Forecasted Book Value Growth 25.26%
Forecasted Cash Flow Growth 39.55%
Forecasted Earnings Growth 28.16%
Forecasted Revenue Growth 15.88%
As of Aug. 24, 2016

IBB Performance

  Returns Total Returns
1M 1.73% 1.73%
3M 4.18% 4.25%
6M 9.04% 9.18%
1Y -16.56% -16.45%
3Y 44.67% 45.13%
5Y 209.6% 212.2%
As of Aug. 26, 2016

IBB Comparables

Edit

IBB Attributes

Key Dates
Inception Date 2/5/2001
Last Annual Report Date 3/31/2016
Last Prospectus Date 8/1/2016
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan Yes
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No

IBB Excel Add-In Codes

  • Name: =YCI("IBB","name")
  • Broad Asset Class: =YCI("IBB", "broad_asset_class")
  • Broad Category: =YCI("IBB", "broad_category_group")
  • Prospectus Objective: =YCI("IBB", "prospectus_objective")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.